(Q39510433)

English

Determination of alpha1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA.

scientific article published on June 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Determination of alpha1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

1 reference

ORCID Public Data File 2021

author name string

Jung K

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Brux B

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Lein M

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Knäbich A

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sinha P

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Rudolph B

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Schnorr D

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Loening SA

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

0 references

publication date

1 June 1999

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1160-7; discussion 1167-8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Serum Prostate Specific Antigen Complexed toα1-Antichymotrypsin as an Indicator of Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900080-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical utility of measurements of free and total prostate-specific antigen (PSA): a review

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900080-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900080-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of an immunoassay specific for the PSA-ACT complex without the problem of high background

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900080-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors influencing the ratio of free to total prostate-specific antigen in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900080-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The percentage of free prostate specific antigen is an age-independent tumour marker for prostate cancer: establishment of reference ranges in a large population of healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900080-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Software for illustrative presentation of basic clinical characteristics of laboratory tests--GraphROC for Windows

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900080-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900080-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of serum concentrations of PSA-ACT complex with total PSA in random and serial specimens from patients with BPH and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900080-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Advantages of replacing the total PSA assay with the assay for PSA-alpha 1-antichymotrypsin complex for the screening and management of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900080-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation of free PSA/total PSA in serum for differentiating between patients with prostatic cancer and benign hyperplasia of the prostate: which cutoff should be used?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900080-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900080-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen forms a complex with and cleaves alpha 1-protease inhibitor in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900080-1

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo and in vitro complex formation of prostate specific antigen with alpha 1-anti-chymotrypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900080-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen and its complexes with alpha 1-antichymotrypsin in the plasma of patients with prostatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900080-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of complexed PSA improves specificity for early detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900080-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(99)00080-1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39510433&oldid=1856227054"